MedPath

Safety report of Siddha polyherbal formulation Kabasura Kudineer.

Phase 3
Registration Number
CTRI/2022/05/042510
Lead Sponsor
Central Council for Research in Siddha
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Any subjects willing to participate in the study (age 18 -60 yrs) from the contingent, CISF

Exclusion Criteria

1. Covid positive cases

2. Subjects under immunotherapies or steroids or any other antiviral drugs

3. Subjects who are unsuitable as per the logical derivations of the investigators

4. Subjects are unwilling to enroll/participate or continue the drug period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath